Leukemia inhibitory factor protein and receptors are expressed in the bovine adrenal cortex and increase cortisol and decrease adrenal androgen release

Domestic Animal Endocrinology

Volumn 35, Issue 2, 2008, Pages 217-230

  Woods, Alison M ^a   McIlmoil, Christopher J ^a   Rankin, Ernestina N ^a   Packer, Alissa A ^a   Stevens, Jessica C ^a   Macievic, Jeffrey A ^a   Brown, Aaron B ^a   Porter, James P ^a   Judd, Allan M ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Adrenal; Androgen; Cortisol; Cytokine; Leukemia inhibitory factor

Indexed keywords

ANDROGEN; CORTICOTROPIN; HYDROCORTISONE; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MESSENGER RNA;

ADRENAL CORTEX; ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; CATTLE; DOSE RESPONSE; FEMALE; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; WESTERN BLOTTING;

ADRENAL CORTEX; ADRENOCORTICOTROPIC HORMONE; ANDROGENS; ANIMALS; BLOTTING, WESTERN; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HYDROCORTISONE; IMMUNOHISTOCHEMISTRY; LEUKEMIA INHIBITORY FACTOR; RECEPTORS, OSM-LIF; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

BOVINAE;

EID: 51749094146     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2008.05.005     Document Type: Article

References (60)

1. Beishuizen A., Thijs L.G., Haanen C., and Vermes I. Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 86 6 (2001) 2811-2816
2. Beishuizen A., Thijs L.G., and Vermes I. Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve?. Crit Care 6 5 (2002) 434-438
3. Almeida P.E., Weber P.S., Burton J.L., and Zanella A.J. Depressed DHEA and increased sickness response behaviors in lame dairy cows with inflammatory foot lesions. Domest Anim Endcorinol 31 1 (2008) 89-99
4. Beishuizen A., and Thijs L.G. The immunoneuroendocrine axis in critical illness: beneficial adaptation or neuroendocrine exhaustion?. Curr Opin Crit Care 10 6 (2004) 461-467
5. Vermes I., and Beishuizen A. The hypothalamic-pituitary-adrenal response to critical illness. Best Pract Res Clin Endocrinol Metab 15 4 (2001) 495-511
6. Alesci S., and Bornstein S.R. Neuroimmunoregulation of androgens in the adrenal gland and the skin. Horm Res 54 5-6 (2000) 281-286
7. Parker C.R. Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids 64 9 (1999) 640-647
8. Straub R.H., Schuld A., Mullington J., Haack M., Scholmerich J., and Pollmacher T. The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. J Endocrinol 175 2 (2002) 467-474
9. Straub R.H., Lehle K., Herfarth H., Weber M., Falk W., Preuner J., et al. Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor. Eur J Endocrinol 146 3 (2002) 365-374
10. Bornstein S.R., Rutkowski H., and Vrezas I. Cytokines and steroidogenesis. Mol Cell Endocrinol 215 1-2 (2004) 135-141
11. Ehrhart-Bornstein M., Hinson J.P., Bornstein S.R., Scherbaum W.A., and Vinson G.P. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. EndocrRev 19 2 (1998) 101-143
12. Judd A.M. Cytokine expression in the rat adrenal cortex. Horm Metab Res 30 6-7 (1998) 404-410
13. Judd A.M., Call G.B., Barney M., McIlmoil C.J., Balls A.G., Adams A., et al. Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion. Ann N Y Acad Sci 917 (2000) 628-637
14. Cardoso E., Arzt E., Coumroglon M., Andrada E.C., and Andrada J.A. Alpha-interferon induces cortisol release by human adrenals in vitro. Int Arch Allergy App Immunol 93 2-3 (1990) 263-266
15. Koldzic-Zivanovic N., Tu H., Juelich T.L., Rady P.L., Tyring S.K., Hudnall S.D., et al. Regulation of adrenal glucocorticoid synthesis by interleukin-10: a preponderance of IL-10 receptor in the adrenal zona fasciculata. Brain Behav Immun 20 5 (2006) 460-468
16. Lo M.J., and Lee S.D. Direct effects of IL-15 on corticosterone secretion by rat adrenocortical cells. Immunol Cell Biol 84 1 (2006) 38-43
17. Michl P., Beikler T., Engelhardt D., and Weber M.M. Interleukin-3 and interleukin-6 stimulate bovine adrenal cortisol secretion through different pathways. J Neuroendocrinol 12 1 (2000) 23-28
18. Tominaga T., Fukata J., Naito Y., Usui T., Murakami N., Fukushima M., et al. Prostaglandin-dependent in vitro stimulation of adrenocortical ateroidogenesis by interleukins. Endocrinology 128 1 (1991) 526-531
19. Woods A.M., and Judd A.M. Interleukin-4 increases cortisol and decreases adrenal androgen release from bovine adrenal cells. Domest Anim Endocrinol 34 4 (2008) 372-382
20. Romero D.G., Vergara G.R., Zhu Z., Covington G.S., Plonczynski M.W., Yanes L.L., et al. Interleukin-8 synthesis, regulation, and steroidogenic role in H295R human adrenocortical cells. Endocrinology 147 2 (2006) 891-898
21. Sekiyama A., Ueda H., Kashiwamura S., and Okamura H. Stress induced, superoxide mediated caspase-1 activation causes plasma cytokines' elevation. Biol Psychiatry 57 8 (2005) 92S
22. Sekiyama A., Ueda H., Kashiwamura S., Sekiyama R., Takeda M., Rokutan K., et al. A stress-induced, superoxide-mediated caspase-1 activation pathway causes plasma IL-18 upregulation. Immunity 22 6 (2005) 669-677
23. Sekiyama A., Ueda H., Kashiwamura S., Nishida K., Yamaguchi S., Sasaki H., et al. A role of the adrenal gland in stress-induced up-regulation of cytokines in plasma. J Neuroimmunol 171 1-2 (2006) 38-44
24. Metcalf D. The unsolved enigmas of leukemia inhibitory factor. Stem Cells 21 1 (2003) 5-14
25. Chesnokova V., and Melmed S. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation. Endocrinology 141 11 (2000) 4032-4040
26. Auernhammer C.J., and Melmed S. Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev 21 3 (2000) 313-345
27. Bamberger A.M., Schulte H.M., Wullbrand A., Jung R., Beil F.U., and Bamberger C.M. Expression of leukemia inhibitory factor (LIF) and LIF receptor (LIF-R) in the human adrenal cortex: implication for steroidogenesis. Mol Cell Endocrinol 162 1-2 (2000) 145-149
28. Barney M., Call G.B., McIlmoil C.J., Husein O.F., Adams A., Balls A.G., et al. Stimulation by interleukin-6 and inhibition by tumor necrosis factor of cortisol release from bovine adrenal zona fasciculata cells through their receptors. Endocrine 13 3 (2000) 369-377
29. Call G.B., Husein O.F., McIlmoil C.J., Adams A., Heckmann R.A., and Judd A.M. Bovine adrenal cells secrete interleukin-6 and tumor necrosis factor in vitro. Gen Comp Endocrinol 118 2 (2000) 249-261
30. Eckert J., and Niemann H. mRNA expression of leukemia inhibitory factor (LIF) and its receptor subunits glycoprotein 130 and LIF-receptor-β in bovine embryos derived in vitro or in vivo. Mol Hum Reprod 4 10 (1998) 957-965
31. Piedrahita J.A., Weaks R., Petrescu A., Shrode T.W., Derr J.N., and Womack J.E. Genetic characterization of the bovine leukemia inhibitory factor (LIF) gene: isolation and sequencing, chromosome assignment and microsatellite analysis. Anim Genet 28 1 (1997) 14-20
32. Gearing D.P., Thut C.J., VandeBos T., Gimpel S.D., Delaney P.B., King J., et al. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J 10 10 (1991) 2839-2848
33. Wallenstein S., Zucker C.L., and Fleiss J.L. Some statistical-methods useful in circulation research. Circ Res 47 1 (1980) 1-9
34. Hedger M.P., and Meinhardt A. Cytokines and the immune-testicular axis. J Reprod Immunol 58 1 (2003) 1-26
35. Akita S., Malkin J., and Melmed S. Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion. Endocrinology 137 7 (1996) 3140-3143
36. Auernhammer C.J., Chesnokova V., and Melmed S. Leukemia inhibitory factor modulates interleukin-1β-induced activation of the hypothalamo-pituitary-adrenal axis. Endocrinology 139 5 (1998) 2201-2208
37. Chesnokova V., Auernhammer C.J., and Melmed S. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response. Endocrinology 139 5 (1998) 2209-2216
38. Sicard F., Ehrhart-Bornstein M., Corbeil D., Sperber S., Krug A.W., Ziegler C.G., et al. Age-dependent regulation of chromaffin cell proliferation by growth factors, dehydroepiandrosterone (DHEA), and DHEA sulfate. Proc Natl Acad Sci USA 104 6 (2007) 2007-2012
39. Fang V.S. Cytotoxic activity of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2,2-dichloroethane (mitotane) and its analogs on feminizing adrenal neoplastic cells in culture. Cancer Res 39 1 (1979) 139-145
40. Mauduit C., Goddard I., Besset V., Tabone E., Rey C., Gasnier F., et al. Leukemia inhibitory factor antagonizes gonadotropin induced-testosterone synthesis in cultured porcine Leydig cells: sites of action. Endocrinology 142 6 (2001) 2509-2520
41. Spangenburg E.E., and Booth F.W. Multiple signaling pathways mediated LIF-induced skeletal muscle satellite cell proliferation. Am J Physiol Cell Physiol 283 1 (2002) C204-C211
42. Edoff K., and Jerregård H. Effects of IL-1β, IL6 or LIF on rat sensory neurons co-cultures with fibroblast-like cells. J Neurosci Res 67 2 (2002) 255-263
43. Gorny G., Shaw A., and Oursler M.J. IL-6, LIF, and TNFα regulation of GM-CSF inhibition of osteoclastogenesis in vitro. Exp Cell Res 294 1 (2004) 149-158
44. Fouladi-Nashta A.A., Andreu C.V., Nijjar N., Heath J.K., and Kimber S.J. Role of leukemia inhibitor factor (LIF) in decidualisation of murine uterine stromal cells in vitro. J Endocrinol 181 3 (2004) 477-492
45. Furue M., Okamoto T., Hayashi Y., Okochi H., Fujimoto M., Myoishi Y., et al. Leukemia inhibitory factor as an anti-apoptotic mitogen for pluripotent mouse embryonic stem cells in a serum-free medium without feeder cells. In Vitro Cell Dev Biol Animal 41 1-2 (2005) 19-28
46. Oshima K., Teo D.T.W., Senn P., Starlinger V., and Heller S. LIF promotes neurogenesis and maintains neural precursors in cell populations derived from spiral ganglion stem cells. BMC Dev Biol (2007) 10.1186/1471-213x-7-112
47. Wenisch C., and Linnau K.F. Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria. J Infect Dis 179 3 (1999) 747-750
48. Thum M.J., Abdalla H.I., Bhaskaran S., Harden E.L., Ford B., Sumar N., et al. The effect of serum concentration of leukaemia inhibitory factor on in vitro fertilization treatment outcome. Am J Reprod Immunol 55 1 (2006) 76-80
49. Tjernlund A., Babilonia B., Nowak P., Kinloch S., Thorborn D., Perrin L., et al. Early induction of leukemia inhibitory factor (LIF) in acute HIV-1 infection. AIDS 20 1 (2006) 11-19
50. Akita S., Akino K., Ren S.G., Melmed S., Imaizumi T., and Hirano A. Elevated circulating leukemia inhibitory factor in patients with extensive burns. J Burn Care Res 27 2 (2006) 221-225
51. Ren S.G., Seliktar J., Li X., Braunstein G.D., and Melmed S. Measurement of leukemia inhibitory factor in biological fluids by radioimmunoassay. J Clin Endocrinol Metab 3 2 (1998) 102-108
52. Sempowski G.D., Rhein M.E., Scearce R.M., and Haynes B.F. Leukemia inhibitory factor is a mediator of Escherichia coli lipopolysaccharide-induced acute thymic atrophy. Eur J Immunol 32 (2002) 3006-3070
53. Breslow M.J. Regulation of adrenal-medullary and cortical blood-flow. Am J Physiol 262 5 (1992) H1317-H1330
54. Heinrick P.C., Behrmann I., Haan S., Hermanns H.M., Mu{combining double acute accent}ller-Newen G., and Schaper F. Principles of interleukin-6(IL)-6 type cytokine signaling and its regulation. Biochem J 374 1 (2003) 1-20
55. Kristensen D.M., Kalisz M., and Nielsen J.N. Cytokine signaling in embryonic stem cells. APMIS 113 11-12 (2005) 756-772
56. Mueller M., Atanasov A., Cima I., CorazzaN, Schoonjans K., and Brunner T. Differential regulation of glucocorticoid synthesis in murine intestinal epithelial versus adrenocortical cell lines. Endocrinology 148 3 (2007) 1445-1453
57. Sapolsky R.M., Romero L.M., and Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21 1 (2000) 55-89
58. Saponaro S., Guarnieri V., Pescarmona G.P., and Silvagno F. Long-term exposure to dehydroepiandrosterone affects the transcriptional activity of the glucocorticoid receptors. J Steroid Biochem Mol Biol 103 2 (2007) 129-136
59. Olech E., and Merrill J.T. DHEA supplementation: the claims in perspective. Clev Clin J Med 72 11 (2005) 965-984
60. Webb S.J., Geoghegan T.E., and Prough R.A. The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab Rev 38 1-2 (2006) 89-116